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MMP-9/Gelatinase B Is a Key Regulator
of Growth Plate Angiogenesis and Apoptosis
of Hypertrophic Chondrocytes
growth plates are characterized by the orderly prolifera-
tion and maturation of chondrocytes in longitudinal col-
umns, forming stratified zones of reserve, proliferative,
maturing, and hypertrophic cartilage (Poole, 1991). Hy-
pertrophic chondrocytes secrete large amounts of a
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Summary A delicate balance between the rate of formation of
calcified cartilage and its vascularization must be main-
Homozygous mice with a null mutation in the MMP-9/ tained in order for bone development to proceed nor-
gelatinase B gene exhibit an abnormal pattern of skel- mally.
etal growth plate vascularization and ossification. Al- Angiogenesis requires invasion by endothelial cells
though hypertrophic chondrocytes develop normally, and localized proteolytic modification of the ECM (In-
apoptosis, vascularization, and ossification are delayed, gber and Folkman, 1989). Proteolysis of the ECM allows
resulting in progressive lengthening of the growth cell migration and may also release stored signaling
plate to about eight times normal. After 3 weeks post- molecules. Matrix metalloproteinases (MMP) are impli-
natal, aberrant apoptosis, vascularization, and ossifi- cated in these processes owing to their ability to cleave
cation compensate to remodel the enlarged growth ECM components (Birkedal-Hansen et al., 1993; Werb,
plate and ultimately produce an axial skeleton of nor- 1997). MMPs are expressed by and around forming
mal appearance. Transplantation of wild-type bone blood vessels (Karelina et al., 1995), and modification
marrow cells rescues vascularization and ossification of MMP activity modulates endothelial cell proliferation
in gelatinase B±null growth plates, indicating that these or tubule formation in several in vitro models of angio-
processes are mediated by gelatinase B±expressing genesis (Murphy et al., 1993; Schnaper et al., 1993;
cells of bone marrow origin, designated chondro-
Fisher et al., 1994). Hyaline cartilage, which is resistant
clasts. Growth plates from gelatinase B±null mice in
to vascular invasion, is rich in angiogenic inhibitors, in-culture show a delayed release of an angiogenic acti-
cluding members of the tissue inhibitor of the metallo-vator, establishing a role for this proteinase in control-
proteinases (TIMP) family (Moses and Langer, 1991).ling angiogenesis.
Gelatinase B (92 kDa gelatinase, MMP-9) degrades
components of the ECM with high specific activity for
Introduction
denatured collagens (gelatin). It can cleave native colla-
gens of type IV, V, and XI, and elastin, but not native
Skeletal development requires the exquisite coordi-
type I collagen, proteoglycans, or laminins. Gelatinase
nation of programs for cellular growth, differentiation,
B can also cleave a variety of non-ECM molecules such
apoptosis, extracellular matrix (ECM) remodeling, and
as IL-1b, substance P, myelin basic protein, and amyloidangiogenesis. Bones form by at least two distinct mecha-
b peptide (reviewed in Vu and Werb, 1998).nisms: intramembranous and endochondral ossification
Gelatinase B has a restricted pattern of expression(Caplan, 1988). Endochondral bone formationpresents a
that changes from development to maturity. It is fre-particularly interesting developmental challenge. During
quently expressed at sites of active tissue remodelingthis process an avascular tissue (cartilage) is replaced
and neovascularization. It is highly expressed duringby one of the most highly vascularized tissues (bone) in
embryonic development by trophoblast cells at the im-the vertebrate body. Endochondral ossification occurs
plantation site and by osteoclasts (Reponen et al., 1994;in the growth plates and epiphyses of long bones. The
Alexander et al., 1996). Later, it is expressed mainly by
inflammatory cells and in pathological processes such
as inflammatory arthritis, tumor invasion, skin blistering7 To whom correspondence should be addressed.
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Figure 1. Generation of Gelatinase B±Null
Mice
(A) Genomic organization of the wild-type and
targeted alleles after homologous recombi-
nation. The location of the fragment used as
a probe in Southern blotting is shown, as well
as the sizes of the two XbaI fragments de-
tected for wild-type and targeted alleles.
(B) Southern blot analysis of genomic DNA.
Fragments corresponding to wild-type (8 kb)
and targeted (5 kb) alleles are shown.
(C) Gelatin zymographic analysis of speencell
lysates. Gelatinolytic activity corresponding
to gelatinase B is shown.
diseases, corneal ulcers, and Alzheimer's disease (re- Gelatinase B±Null Animals Show Abnormal
Development of Growth Platesviewed in Vu and Werb, 1998). Gelatinase B is also impli-
cated in invasive behavior in trophoblasts and meta- in the Long Bones
Gelatinase B is highly expressed in osteoclasts; there-static tumor cells.
In this study we have generated mice deficient in gela- fore, we first examined whether these mice exhibited
signs of defective osteoclast function such as oste-tinase B by targeted mutagenesis and determined the
consequences upon endochondral bone formation. opetrosis or altered trabecular bone density. Initial histo-
logic and radiographic examination of young adult gela-
tinase B±null mice (2 months) revealed no obviousResults
phenotype in the skull or axial skeleton. However, the
long bones (tibia and femurs) of gelatinase B±null miceGelatinase B±Null Mice Are Viable
To inactivate the gelatinase B gene, part of exon 2 and were about 10% shorter than those of wild-type lit-
termates (data not shown).all of intron 2 were replaced with a cassette containing
the neomycin phosphotransferase cDNA (neor ) driven Bone length is determined in part by the activity of
the growth plate during endochondral bone formation.by the phosphoglycerate kinase (PGK) promoter (Figure
1A). The targeting construct was introduced into ZW4 Therefore, we examined growth plates of gelatinase
B±null animals.Tibias, femurs, and metatarsals of homo-(129/Sv) ES cells by electroporation, and resistant colo-
nies were selected with G418. Eight homologously tar- zygous animals had microscopic abnormalities in their
growth plates. We focused onthe metatarsals of postna-geted clones were identified out of 103 clones screened.
Two independent correctly targeted clones were aggre- tal mice because of their small size and convenience;
other appendicular bones (tibia, femur) had similar find-gated with morulas of CD1 mice or injected into blasto-
cysts of C57BL/6 mice. Chimeric males were mated with ings. Growth plates of gelatinase B±null mice had a
lengthened zone of hypertrophic cartilage with no differ-either CD1 or Swiss Black mice, and offspring were
screened with Southern blots of tail DNA for germline ence in the reserveor proliferating zones (Figure 2B). The
same abnormalites were seen in the metatarsal growthtransmission of the targeted allele (Figure 1B). All of the
studies were done using animals derived from the two plates of over 50mice examined from two different back-
grounds (129Sv/CD1 and 129Sv/Swiss Black). The hy-independent ES clones.
Intercrossing of heterozygous animals gave rise to live pertrophic cartilage zone in the gelatinase B±null meta-
tarsals was about twice that of wild-type metatarsals athomozygous offspring with expected Mendelian ratios
and with no obvious phenotypic defects. Homozygous birth (data not shown) and became more pronounced
with the growth of the bones. By 3 weeks postnatal, itnull animals were fertile and survived for at least 24
months. These mice were also viable on pure 129/Sv, was six to eight times as long in the null animals as in
wild-type animals (Figure 2C). The cells in the length-C57BL/6, and FVB/N backgrounds. Homozygous null
animals lacked gelatinase B activity in spleencell lysates ened hypertrophic zone were morphologically normal,
and the matrix calcified normally (Figure 2E). There was(Figure 1C).
MMP-9 Controls Growth Plate Angiogenesis
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Figure 2. Histological Analysis of the Metatarsals of Wild-Type and Gelatinase B±Null Mice
(A) Diagram of the growth plate showing different cartilage zones.
(B) Histological sections of 2-week-old metatarsals stained with hematoxylin/fast green/safranin O. (ep) epiphysis; (c) reserve, proliferation,
and maturation zones; (hc) hypertrophic cartilage; (tb) trabecular bone; (bm) bone marrow. Scale bar 5 200 mm.
(C) Histological sections of 3-week-old metatarsals. Magnified view on the right lower panel shows cortical bone surrounding the hypertrophic
cartilage in gelatinase B±null mice (outlined by white arrows). Black arrows point to capillaries invading from the cortical bone. (hc) hypertrophic
cartilage; (tb) trabecular bone.
(D) Histological sections of 4-week-old metatarsals showing aberrant ossification process in the gelatinase B±null mice (arrows in upper right
panel). The lower left panel shows a bone whose hypertrophic cartilage has been almost completely ossified giving the appearance of
osteopetrosis (arrows). Magnified view on the lower right panel shows a vessel invading from the side (arrow).
(E) Von Kossa staining of 2-week-old metatarsal growth plates. Calcium deposits stain black.
(F) Histological sections of 8-week-old metatarsals.
no difference in the thickness of the cortical bone. How- 2C). Ectopic ossification proceeded rapidly, so that in
some bones the entire zone of hypertrophic cartilageever, the area of metaphyseal trabecular bone was
somewhat shorter in the gelatinase B±null bones (Figure was ossified, leading to a large area of trabecular bone
reminiscent of osteopetrosis (Figure 2D). However, this2C). Cortical bone formed and extended normally and
independently of trabecular bone in the null animals, osteopetrosis resolved with subsequent remodeling,
producing normal appearing bones by 8 weeks (Fig-resulting in a collar of bone surrounding the nonossified
lengthened hypertrophic cartilage, whereas wild-type ure 2F).
hypertrophic cartilage is not surrounded by cortical
bone (Figure 2C). Hypertrophic Chondrocyte Differentiation
Is Normal in Gelatinase B±Null MiceAt 4 weeks of age, ossification in the gelatinase B±null
animals was no longer limited to the distal end of the One mechanism for the lengthened zone of hypertrophic
cartilage is an alteration in the proliferation or maturationhypertrophic cartilage. Ectopic areas of ossification be-
gan to appear within the hypertrophic zone (Figure 2D). of chondrocytes. The number of proliferating cells in-
corporating bromo-deoxyuridine (BrdU) in the growthThis aberrant process appeared to be initiated by inva-
sion of blood vessels from the periphery (Figure 2D), plates was similar in the homozygous null and wild-type
animals at all ages examined (Figure 3; data not shown),which could be seen as early as 3 weeks of age (Figure
Cell
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Figure 3. BrdU Labeling and In Situ Hybrid-
ization with Chondrocyte Markers
Left column panels show metatarsals from
2-week-old wild type and right column panels
show those from gelatinase B±null mice. Cells
that have incorporated BrdU stain brown.
Arrow points to the secondary site of osssifi-
cation. Zones of expression of Indian hedge-
hog (ihh), bone morphogenetic protein-6
(bmp-6), collagen type II (col2A1), and colla-
gen type X (colXA1) are shown by dark-field
photography of in situ hybridization with anti-
sense mRNA probes. (hc) hypertrophic carti-
lage. Scale bar 5 200 mm.
indicating that increased proliferation was not a mecha- bmp-6, and col2A1 between the wild-type and gela-
tinase B±null growth plates at 1 and 2 weeks postnatalnism leading to the expanded zone of hypertrophic carti-
lage. BrdU-positive cellswere also seen in theepiphyses (Figure 3; data not shown). The expression of ihh and
bmp-6 was not detected in epiphyseal sites or in gela-of wild-type metatarsals at 2 weeks of age, where the
secondary (epiphyseal) site of ossification had already tinase B±null growth plates after 3 weeks of age (data
not shown) as observed previously in wild-type bonesstarted. In the gelatinase B±null animals, the secondary
ossification sites were delayed until 2.5 weeks of age (Iwasaki et al., 1997). In contrast to these markers of
early differentiation, collagen type X (colXA1), a specific(data not shown). However, by 3 weeks of age these
sites were completely ossified, as in wild-type animals marker of all hypertrophic chondrocytes (Elima et al.,
1993), showed an expanded domain of expression cor-(Figure 2B). Interestingly, there was no discernable in-
crease in the hypertrophic cartilage zone in these epi- responding to the lengthened zone of hypertrophic carti-
lage (Figure 3). This finding indicates that the cells pres-physeal sites.
ent in the greatly expanded hypertrophic cartilage zoneA distinct pattern of stage-specific gene expression
remained metabolically active.characterizes chondrocyte differentiation. Indian hedge-
hog (ihh) is expressed by mature and upper hypertrophic
chondrocytes and is important in thecontrol of chondro- Apoptosis of Hypertrophic Chondrocytes Is
cyte maturation (Lanske et al., 1996; Vortkamp et al., Delayed in the Gelatinase B±Null Mice
1996). Bone morphogenetic protein-6 (bmp-6 ) is also During endochondral ossification, terminal hypertrophic
expressed by upper hypertrophic chondrocytes, and chondrocytes adjacent to the invading capillaries un-
collagen type 2 (col2A1) is expressed by chondrocytes dergo apoptosis (Farnum and Wilsman, 1989; Hatori et
in the reserve, proliferative, mature, and upper hypertro- al., 1995). The enlargement of the hypertrophic cartilage
phic zones. In situ hybridizations showed no differences zone could be due to altered hypertrophic chondrocyte
death or tissue remodeling (ossification) at the calcifiedin the pattern of expression of mRNA transcripts for ihh,
MMP-9 Controls Growth Plate Angiogenesis
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Figure 4. Apoptotic Cells in the Metatarsal
Growth Plate
(A and B) Propidium iodide (PI) and ApopTag
(Apop) staining of 1- and 2-week-old metatar-
sal growth plates from wild-type and gela-
tinase B±null mice. Arrows point to terminal
hypertrophic chondrocytes that are apo-
ptotic. Apoptotic cells are also present in the
bone marrow, perichondrium, and periosteum.
(hc) hypertrophic cartilage.
(C and D) PI and Apop staining of 3-week-
old (C) and 4-week-old (D) metatarsal growth
plates.Arrows inthe gelatinase B±null growth
plates show apoptotic chondrocytes in the
middle of the hypertrophic cartilage at three
weeks (C) or in the vascularized and ossified
hypertrophic cartilage at 4 weeks (D).
Scale bars 5 200 mm.
cartilage±bone interface. In both wild-type and gelatinase was followed by ectopic ossification, evident by 4 weeks
of age, with chondrocyte apoptosis around the areas ofB±null growth plates, apoptotic chondrocytes were found
only in the terminal row adjacent to the ossification front ossification throughout the hypertrophic zone (Figure 4D).
(Figures 4A and 4B). This indicates that in the gelatinase
B±null growth plates there was a delay in hypertrophic Cells at the Hypertrophic Cartilage±Bone
Junction Express Gelatinase Bchondrocyte apoptosis coupled with delayed ossifica-
tion of hypertrophic cartilage. Gelatinase B could either High expression of gelatinase B was seen in two popula-
tions of cells: multinucleated osteoclasts on trabecularhave a direct effect on apoptosis or on ossification.
By 3 weeks of age, when the hypertrophic zone had bone surfaces and smaller, mostly mononuclear cells
at the transverse septae of the cartilage±bone junctionlengthened up to 8-fold, aberrant apoptosis began in
the middle of the hypertrophic cartilage (Figure 4C). This that lead the vascular invasion front (Figures 5A±5D).
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Although the distribution of cells expressing gelatinase
B was similar to that of cells expressing tartrate-resis-
tant acid phosphatase (TRAP), a marker for the osteo-
clast cell lineage (Figures 5E and 5F), there were also
TRAP-negative cells expressing gelatinase B. Gelatinase
B expression did not colocalize with staining with an
antibody to PECAM-1, an endothelial cellsurface marker
(Figures 5I and 5J), suggesting that cells expressing
gelatinase B are not endothelial cells. Gelatinase B pro-
tein was present in small stellate cells and also tightly
associated with the ECM localized to the junction be-
tween hypertrophic cartilage and the vascular invasion
front (Figures 5G and 5H).
Bone Marrow Transplantation Corrects
the Gelatinase B±Null Phenotype
Three major cell types are present in the ossifying
growth plate: mesenchymal cells that give rise to osteo-
blasts, hematopoietic cells that give rise to osteoclasts
and blood cells, and endothelial cells. To determine the
origin of the critical cells whose lack of gelatinase B
expression leads to the defect in the gelatinase B±null
mice, we irradiated newborn gelatinase B±null mice and
reconstituted their bone marrow with wild-type cells.
The presence of engrafted functional wild-type bone
marrow cells in the transplanted mice was confirmed
by the presence of gelatinolytic activity corresponding
to gelatinase B in their spleens (data not shown). At 3
weeks after transplantation, the zones of hypertrophic
cartilage in the metatarsal growth plates of treated mice
were reduced in size, intermediate between untreated
gelatinase B±null and wild-type mice (Figure 6A). At 4
weeks after transplantation, the growth plates of treated
mice did not show the aberrant ossification seen in their
untransplanted littermates (Figure 6A). Cells expressing
gelatinase B appeared at the cartilage±bone junction in
the transplanted mice, some of which corresponded to
TRAP-positive cells (Figure 6B). These data indicate that
the critical cells are of bone marrow origin.
Release of an Angiogenic Activator from Gelatinase
B±Null Growth Plate in Culture Is Delayed
The delay in ossification of the growth plates in gela-
tinase B±null animals may be due to either defective
ECM remodeling or impaired angiogenesis, or both. We
Figure 5. Expression of Gelatinase B at the Growth Plate
used an in vitro angiogenesis assay to compare the
(A±D) Bright-field (A and B) and dark-field (C and D) photographs angiogenic activity of growth plates from wild-type ver-
of a section of 3-week-old wild-type metartarsal growth plate hybrid-
sus gelatinase B±null mice. Hypertrophic cartilage, in-ized with a gelatinase B antisense mRNA probe. Arrows point to
cluding the immediately adjacent vascular invasion frontgelatinase B expressing cells at the cartilage±bone junction. (B) and
(D) are magnified views of (A) and (C). (ep) epiphysis. Scale bar 5 where gelatinase B is expressed, was dissected out of
100 mm. 2-week-old wild-type and gelatinase B±null metatarsals.
(E and F) TRAP staining of an adjacent section (E) and magnified These were embedded into collagen gels containing
view (F) showing TRAP positive (red) cells at the cartilage±bone
randomly distributed bovine microvascular endothelialjunction (white arrows) and on the trabecular bone surfaces (black
cells. In this assay, wild-type cartilage induced a dra-arrows). Note the distribution of TRAP-positive cells is similar to
matic response within a few days in culture, with thethat of gelatinase B±expressing cells.
(G and H) Immunohistochemistry of 3-week-old wild type metatarsal radial alignment, proliferation, and migration of endothe-
growth plate with an antibody to gelatinase B, showing staining at lial cells toward the embedded cartilage (Figures 7A and
the cartilage bone juction and trabecular surfaces. Magnified view 7C). In contrast, endothelial cells remained in a random
(H) shows staining of ECM and stellate cells (arrow). distribution around the gelatinase B±null cartilage (Fig-
(I and J) Immunohistochemistry of 3-week-old wild-type and gela-
ure 7B).When both wild-type and gelatinase B±null carti-tinase B±null metatarsal growth plates with an antibody to PECAM-1
lage were placed side by side on the same collagen gel,showing staining of blood vessels at the cartilage±bone junction
(white arrows) and in between trabecular bones (black arrows). the presence of gelatinase B±null cartilage did not affect
MMP-9 Controls Growth Plate Angiogenesis
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Figure 6. Growth Plates of Gelatinase B±Null Mice after Bone Marrow Transplantation
(A) Histological sections of metatarsals from untransplanted and bone marrow (BM) transplanted mice at 3 and 4 weeks after transplantation.
Arrow points to area of ectopic ossification in the untransplanted 4-week-old growth plate. Scale bar 5 200 mm.
(B) TRAP staining and in situ hybridization with an antisense mRNA gelatinase B probe showing that gelatinase B±expressing cells, some of
which correspond to TRAP-positive cells, appear at the cartilage±bone junction and on the trabecular bone surfaces after transplantation
(arrows).
the angiogenic response to wild-type cartilage (Figure implant or in osteopetrosis. The gelatinase B±null ani-
mals developed to term, survived normally after birth,7E). When the gelatinase B±null cartilage was main-
tained in the collagen gel for more than a week, it began and were fertile. Therefore, while gelatinase B may play
a role in implantation, bone resorption, and other physio-to induce an angiogenic response (Figure 7D) consistent
with the in vivo observation that the vascularization and logical processes, other enzymes either play a more
dominant role or are able to compensate for the lackossification of hypertrophic cartilage in the gelatinase
B±null growth plate were only delayed until 3 weeks post- of gelatinase B. Interestingly, deficiency of the closely
related gelatinase A (MMP-2) does not appear to resultnatal.
in any significant developmental or physiological impair-
ment (Itoh et al., 1997).Discussion
In this study we have demonstrated a developmentally Gelatinase B Is Involved in Endochondral
Bone Formationrestricted function for gelatinase B. Our data show that
gelatinase B functions in the control of hypertrophic The lack of gelatinase B causes a delay in endochondral
ossification. This is a complex and tightly regulated pro-cartilage vascularization and ossification. Thus, we have
identified a gene that specifically affects cartilage vas- cess. Normal long bone development requires proper
growth and differentiation of cartilage cells (chondro-cularization. This specific function of gelatinase B was
unexpected. A role in implantation and bone resorption genesis), the regulated replacement of cartilage by bone
(osteogenesis), and normal bone remodeling. Many genehas been postulated for gelatinase B owing to its high
expression in trophoblasts and osteoclasts. Surpris- products are involved in this highly orchestrated net-
work of events. Parathyroid hormone-related peptideingly, lack of gelatinase B did not result in failure to
Cell
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Figure 7. In Vitro Angiogenesis Assay
(A±C) Hypertrophic cartilage from 2-week-old
wild-type (A) and gelatinase B±null (B) mice
after one week in a collagen gel coculture
with endothelial cells, showing an angiogenic
response from the endothelial cells only to
wild-type cartilage. Magnified view (C) shows
tubular structures formed by endothelial cells
surrounding the wild-type hypertrophic car-
tilage.
(D) Gelatinase B±null hypertrophic cartilage
after 2.5 weeks in coculture with endothelial
cells, showing an angiogenic response.
(E) Wild-type and gelatinase B±null cartilage
after one week side by side in coculture with
endothelial cell, showing angiogenic response
only to wild-type cartilage that is not abro-
gated by the presence of the gelatinase
B±null cartilage.
(PTHrP), its receptor, and the ihh gene product regulate in the gelatinase B±null animals was slightly delayed,
but ossification was completed timely and there was nochondrocyte growth and maturation (Amizuka et al.,
1996; Lanske et al., 1996; Vortkamp et al., 1996). The abnormal accumulation of hypertrophic cartilage.
transcription factor Cbfa1 is necessary for the differenti-
ation of osteoblasts and the formation of bone matrix
(Ducy et al., 1997; Komori et al., 1997; Otto et al., 1997). Angiogenesis Is Rate Limiting in the Process
of Endochondral OssificationDefects in genes such as csf-1, c-fos, and c-src, which
affect the function or development of osteoclasts, lead A critical step in the process of endochondral ossifica-
tion is the vascularization of hypertrophic cartilage. Thisto defects in bone remodelingwith consequent develop-
ment of osteopetrosis (Yoshida et al., 1990; Soriano et process has three distinct components: the initial inva-
sion of capillaries into the cartilaginous anlage to estab-al., 1991; Grigoriadis et al., 1994).
The gelatinase B±null mice displayed an abnormally lish the marrow cavity and the growth plates; continuing
vascularization coupled with ossification of the growinglarge hypertrophic cartilage zone that was not due to
abnormal growth and differentiation of chondrocytes, growth plates; and vascularization and ossification of
the epiphysis. The initial capillary invasion appears toas shown by the normal pattern of BrdU incorporation
and of the expression of ihh, bmp-6, and col2A1, mark- require the formation of a bone collar around the carti-
lage anlage. The cartilageous limbs in mice with a nullers of proliferating and maturing chondrocytes. In con-
trast, mice deficient in FGFR-3 and cGMP-dependent mutation in Cbfa1, a gene essential for osteoblast devel-
opment, have calcified hypertrophic cartilage but noprotein kinase II have enlarged hypertrophic cartilage
zones secondary to abnormal chondrocyte proliferation bone formation and are not vascularized (Komori et al.,
1997; Otto et al., 1997). Lack of gelatinase B does notand differentiation (Deng et al., 1996; Pfeifer et al., 1996).
The gelatinase B±null mice had delayed endochondral appear toaffect significantly the initial capillary invasion.
In E18 embryos the cartilaginous metatarsals are notossification. This defect was confined to the ossification
of growth plate cartilage. There were no obvious effects yet vascularized, and in newborn mice the growth plates
are already well established in both wild-type and gela-on ossification of the epiphyses or of intramembranous
bones. The initiation of the epiphyseal ossification sites tinase B±null animals (data not shown). This does not
MMP-9 Controls Growth Plate Angiogenesis
419
exclude the possibility of a short delay in the initial capil- death, and mammary gland involution (Chen and Strick-
lary invasion that resolves within this period. The vascu- land, 1997; as reviewed in Werb, 1997) and would pro-
larization and ossification of the epiphysis were also not vide a rational and straightforward role for gelatinase B
significantly affected by the lack of gelatinase B. in the growth plate. However, another possibility is that
Gelatinase B deficiency greatly affected the vasculari- gelatinase B controls angiogenesis by generating an
zation and ossification of the growth plates. This pro- angiogenic signal. In either case, lack of gelatinase B
cess requires the resorption of cartilage matrix and the would result in the same phenotype: delayed chondro-
growth and invasion of capillaries followed by the depo- cyte apoptosis coupled with delayed vascularization
sition of bone matrix by osteoblasts onto the partially and ossification.
resorbed cartilage scaffold. Capillary ingrowth into the
cartilage occurs by angiogenesis, as suggested by elec-
tron microscopic study of vascular casts of growth Gelatinase B Is a Key Regulator of Growth
plates (Aharinejad et al., 1995). This vascularization has Plate Angiogenesis
to be tightly controlled and coordinated with the forma- We found that explants of 2-week-old wild-type hyper-
tion of hypertrophic cartilage for normal bone develop- tropic cartilage (and theadjacent area of trabecular bone
ment. Our data indicate that gelatinase B participates where gelatinase B is located) immediately released po-
in this regulation, since its absence leads to a delay tent angiogenic activity in in vitro angiogenesis assays,
in hypertrophic chondrocyte apoptosis, vascularization, whereas there was a delay in the release of angiogenic
and ossification, thereby leading to an abnormal accu- activity from explants of the corresponding tissue from
mulation of hypertrophic cartilage. gelatinase B±null animals. Thus, one function of gela-
One possible function of gelatinase B is to degrade tinase B is to generate angiogenic activators or to inacti-
cartilage matrix. Lack of ECM resorption would then vate angiogenic inhibitors. Gelatinase B may release
lead to retardation of capillary ingrowth for a purely angiogenic molecules sequestered in the ECM. There
mechanical reason, i.e., lack of a cleared path. Alterna- is precedent for proteolytic release and activation of
tively, cartilage matrix may act as a specific inhibitor to growth factors. For example, stromelysin, interstitial col-
vascular invasion. However, it is unlikely that the defect lagenase, and plasmin can degrade perlecan and re-
in gelatinase B deficiency is a deficit in generic ECM lease bound FGF (Whitelock et al., 1996), and hepato-
degradation. There are other proteinases expressed in cyte growth factor (HGF) is proteolytically activated by
the growth plates, including collagenase-3, stromelysin-1, urokinase (Naldini et al., 1995).
gelatinase A, and the cathepsins (Brown et al., 1989; What angiogenic activity might be regulated by gela-
Ohsawa et al., 1993; Rantakokko et al., 1996), that
tinase B? Several putative angiogenic factors have been
should produce ECM degradation. Cathepsin B and in-
identified in hypertrophic cartilage, while resting hyaline
terstitial collagenase have been shown to be sufficient
cartilage is rich in antiangiogenic activities. aFGF, bFGF,
for the degradation of type X collagen, the major colla-
and endothelial cell stimulating factor (ESAF) have beengen of hypertrophic cartilage (Sireset al., 1995). An alter-
found in hypertrophic cartilage (Brown et al., 1987; Jin-native hypothesis is that gelatinase B is required to gen-
gushi et al., 1995). Other angiogenic activities secretederate specific signals that are essential for the control
by hypertrophic chondrocytes in culture have been re-of growth plate hypertrophic chondrocyte apoptosis
ported, including transferrin and a 120 kDa factor thatand/or vascularization and ossification.
is up-regulated by vitamin D (Alini et al., 1996; Carlevaro
et al., 1997). Gelatinase B may release these from intra-Hypertrophic Chondrocyte Apoptosis Is Regulated
cellular or ECM storage sites, or it may generate (a) yetby Gelatinase B at the Growth Plate
uncharacterized factor(s).During endochondral ossification, the terminal hypertro-
The delay in the release of an angiogenic activity fromphic chondrocytes, the cells situated in the last row
gelatinase B±null growth plates in culture is consistentof hypertrophic cartilage in proximity to the invading
with the observation that the ossification of hypertrophiccapillary loops, undergo apoptosis. Apoptosis of the
cartilage in gelatinase B±null mice was only delayed,terminal chondrocytes may serve as a signal leading to
not completely inhibited. Thus, other mechanisms forvascular invasion. Alternatively, vascular invasion may
regulating angiogenic activities at the growth plates ex-cause apoptosis of the chondrocytes in contact with
ist. The normal development of bone must depend on ainvading vessels, perhaps from dissolution of the sur-
delicate balance of angiogenic activators and inhibitors.rounding ECM. One significant finding in the gelatinase
B±null growth plates is that even though there is an
expanded area of hypertrophic cartilage, still only the
Excess Hypertrophic Cartilage Is Remodeledterminal cells undergo apoptosis. This suggests that
by Aberrant Chondrocyte Apoptosis andchondrocytes do not go through an automatic progres-
Vascularization in the Gelatinasesion of proliferation, maturation, hypertrophy, and apo-
B±Null Growth Plateptosis, but that apoptosis of terminal hypertrophic chon-
At 3 weeks postnatal, aberrant apoptosis was evidentdrocytes is functionally coupled to vascularization and
in the enlarged gelatinase B±null hypertrophic cartilage.ossification so that only the cells in contact with the
Although it is possible that this zone has become sovascular invasion front undergo cell death. Gelatinase
large that nutrients in the center become limiting, thisB could function to cause chondrocyte apoptosis and
seems unlikely given the size of growth plates in largerindirectly allow vascularization and ossification. Protein-
species such as human and bovine. The gelatinase B±nullases, and associated ECM degradation, lead to apopto-
sis in several systems including development, neuronal hypertrophic cartilage was also surrounded by a collar
Cell
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of cortical bone because intramembranous bone forma- cartilage (Anderson and Parker, 1966; Schenk et al.,
1968; Lewinson and Silbermann, 1992). Because gela-tion isunaffected in thesemice, and cortical bone forma-
tion proceeded in an autonomous manner indepen- tinase B±expressing cells are intimately associated with
the capillary invasion front and are important for thedently of the ossification of the hypertrophic cartilage.
This collar of cortical bone could also limit the delivery remodeling of cartilage, we propose that these cells
are chondroclasts. However, the possibility remains thatof nutrients.
By 4 weeks of age, an abnormal pattern of vasculariza- cells expressing gelatinase B are responsible for the
regulation of angiogenesis and that other cells, perhapstion and ossification took place in the hypertrophic carti-
lage of gelatinase B±null mice. This vascularization and the endothelial cells themselves as has been suggested
(Schenk et al., 1968), are responsible for cartilage re-ossification occurred haphazardly within the zone and
appeared to be initiated by capillaries invading from sorption and thus are the true ªchondroclasts.º
the peripheral cortical bone, very much like the initial
Experimental Proceduresvascular invasion of the cartilage anlage. Although the
signals that initiate this abnormal angiogenesis are un-
Construction of Targeting Vectorknown, apoptosis of the hypertrophic chondrocytes pre-
The mouse gelatinase B gene was cloned from a 129/Sv genomic
ceded vascularization with the appearance of apoptotic library in a bacteriophage P1 vector (Genome Systems, St. Louis,
chondrocytes in the center of hypertrophic cartilage of MO). A targeting construct was generated in pBluescript SK (Stra-
3-week-old growth plates and without any obvious cap- tagene) that included 5.3 kb of 59 homology and 3.1 kb of 39 homol-
ogy. The 59 homology included 4.7 kb of promoter sequence, exonillaries in the vicinity.
1, intron 1, and 28 bp of exon 2. The 39 homology begins at the 59
end of exon 3 and extends to a point within intron 9. A cassette
Are There Two Types of Hypertrophic Cartilage? containing the neomycin phosphotransferase cDNA driven by the
phosphoglycerate kinase promoter (PGK-Neo) was used to replaceWhy does ossification of growth plate cartilage require
most of exon 2 and all of intron 2. The targeting construct wasgelatinase B? One notable finding is that ihh is ex-
linearized with NotI prior to electroporation into embryonic stempressed by chondrocytes at the growth plate but not
cells.
by those in the epiphyses (Iwasaki et al., 1997). The
expression of ihh therefore distinguishes growth plate Generation of Gelatinase B±Null Mice
cartilage, whose conversion into bone appears to be The targeting construct was introduced by electroporation into ZW4
(129/Sv, Taconic) ES cells isolated by standard methods. Selecteddifferent from the other sites in the requirement for gela-
G418-resistant clones were screened by Southern blot analysis oftinase B. Moreover, when ihh is down-regulated in the
XbaI-digested genomic DNA, probed with a PvuII±XbaI fragmentgrowth plateat three weekspostnatal, an abnormal ossi-
that was not part of the targeting construct. Heterozygous ES cellsfication process occurs in the enlarged gelatinase B±null
were aggregated with morulas of CD1 mice or injected into blasto-
growth plates. This gelatinase B±independent ossifica- cystsof C56BL/6Jmice and transferred intouteri of pseudopregnant
tion may be similar to the normal ossification of sites females. Chimeric males were mated with either CD1 or Swiss Black
females, and offspring were screened by Southern blot analysis ofthat do not have ihh expression, such as the epiphyses.
tail genomic DNA. Heterozygous littermates were mated to obtainThese observations lead toa model of two distinct endo-
homozygous animals. Spleen lysates were analyzed for loss of gela-chondral ossification processes. Endochondral bone
tinase B activity by gelatin SDS-substrate gel zymography (Fisher
formation from hypertrophic cartilage that expresses and Werb, 1995).
ihh, such as the growth plate, would require gelatinase
B, whereas ossification of hypertrophic cartilage that Histological Analysis
does not express ihh, such as in the epiphysis, would Bones were fixed in 4% paraformaldehyde overnight and decalcified
in 0.5 M EDTA (pH 7.4) for 7±10 days at 48C prior to embedding innot require gelatinase B.
paraffin. Sections (4 mm) were stained with hematoxylin/fast green/
safranin O. TRAP staining was done using a leukocyte acid phospha-
In Search of the Chondroclast tase kit (Sigma, St. Louis, MO). For frozen sections, freshly dissected
bones were snap frozen in liquid nitrogen, embedded in OCT (Tis-Gelatinase B is expressed by osteoclasts and by cells
sue-Tek) at 2208C, and cut into 10 mm sections. Von Kossa stainingat the junction between cartilage and bone in the normal
for mineralization was done on undecalcified frozen sections bygrowth plates. Gelatinase B±expressing cells at the
incubating the slides in 5% silver nitrate for 5 min under UV light,
chondro-osseous junction have several interesting fea- followed by 3 min in 5% sodium thiosulfate, and subsequent coun-
tures. They lead the invading capillaries. They are de- terstaining with hematoxylin.
rived from bone marrow cells. The osteopetrotic c-fos-
In Situ Hybridizationnull and the op/op mice, which lack osteoclasts, show a
Paraffin sections were placed on acid-etched, TESPA-treated slidesmilder growth plate defect than that of gelatinase B±null
and prepared for in situ hybridization as described (Albrecht etmice (unpublished data). These data suggest that the
al., 1997). Plasmids were linearized with the appropriate restriction
majority of gelatinase B-expressing cells at thechondro- enzymes to transcribe either sense or antisense 33P- or 35S-labeled
osseous junction belong to the macrophage/osteoclast riboprobes (ihh, bmp-6, colIIA1, and colXA1 probes were described
lineage. Although some of these cells express TRAP in Albrecht et al., 1997; gelatinase B probe was described in Repo-
nen et al., 1994). Slides were washed at a final stringency of 658Cand may be osteoclast precursors, they may also be of
in 23 SSC, dipped in emulsion, and exposed for 3±7 days (for 33P-a different mononuclear phagocyte lineage divergent
labeled probes) or 1±2 weeks (for 35S-labeled probes). Slides werefrom the osteoclast line prior to a commited precursor.
counterstained with hematoxylin or Hoechst 33342.
Perivascular cells have been observed at the growth
plates associated with invading vascular loops and have Detection of BrdU-Labeled and Apoptotic Cells
been postulated to be chondroclasts, a hypothesized Mice were injected intraperitoneally with 10 mg/ml BrdU (Sigma, St.
Louis, MO) at doses of 0.01 ml/g 1 hr prior to sacrifice. Bones werecell type of obscure origin whose function is to resorb
MMP-9 Controls Growth Plate Angiogenesis
421
fixed and processed for paraffin sections as above. Slides were References
immunostained with an antibody against BrdU using a kit from
Zymed (South San Francisco, CA). Apoptotic cells were identified Aharinejad, S., Marks, S.C., Jr., Bock, P., MacKay, C.A., Larson,
E.K., Tahamtani, A., Mason-Savas, A., and Firbas, W. (1995). Micro-with the TUNEL method with fluorescein-conjugated antibody using
a kit from Oncor (Gaithersburg, MD). vascular pattern in the metaphysis during bone growth. Anat. Rec.
242, 111±122.
Albrecht, U., Eichele, G., Helms, J.A., and Lu, H. (1997). Visualization
Immunohistochemistry of gene expression patterns by in situ hybridization. In Molecular
Sections were deparaffinized, baked at 608C for 1 hr, immersed in and Cellular Methods in Developmental Toxicology, G.P. Daston,
5% H2O2 in PBS for 5 min, washed in PBS, treated with 0.1 M glycine ed. (Boca Raton: CRC Press), pp. 23±48.
for 1 min, washed in PBS, then blocked in the following solutions
Alexander, C.M., Hansell, E.J., Behrendtsen, O., Flannery, M.L.,in a stepwise fashion with PBS washes in between: 5% nonfat dry
Kishnani, N.S., Hawkes, S.P., and Werb, Z. (1996). Expression andmilk in PBS for 10 min, 1 mg/ml ovalbumin in PBS for 10 min, and
function of matrix metalloproteinases and their inhibitors at the ma-5% sheep serum in PBS for 30 min. After incubation in 5% sheep
ternal-embryonic boundary during mouse embryo implantation. De-serum, the blocking solution was removed and primary antibody was
velopment 122, 1723±1736.added. Rabbit anti-mouse gelatinase B was generated as described
Alini, M., Marriott, A., Chen, T., Abe, S., and Poole, A.R. (1996). Apreviously (Behrendtsen et al., 1992); monoclonal rat anti-mouse
novel angiogenic molecule produced at the time of chondrocytePECAM-1 was a gift from Dr. S. Baldwin (University of Pennsylvania).
hypertrophy during endochondral bone formation. Dev. Biol. 176,Antibody was diluted in PBS with 1 mg/ml BSA. Slides were incu-
124±132.bated in primary antibody overnight at 48C, then washed in PBS,
Amizuka, N., Henderson, J.E., Hoshi, K., Warshawsky, H., Ozawa,blocked again with 5% sheep serum in PBS, and incubated in sec-
H., Goltzman, D., and Karaplis, A.C. (1996). Programmed cell deathondary antibody (biotinylated anti-rabbit or anti-rat Ig from Amer-
of chondrocytes and aberrant chondrogenesis in mice homozygoussham, Cleveland, OH) at ambient temperature for 1 hr. Slides were
for parathyroid hormone-related peptide gene deletion. Endocrinol-subsequently washed in PBS and incubatedwith horseradish perox-
ogy 137, 5055±5067.idase±conjugated streptavidin (Amersham, Cleveland, OH) at room
temperature for 1 hr, then washed in PBS and developed with True Anderson, C.E., and Parker, J. (1966). Invasion and resorption in
Blue substrate (Kirkeggard and Perry Laboratory, Gaithersburg, MD). endochondral ossification. An electron microscopic study. J. Bone
Joint Surger. Am. 48, 899±914.
Behrendtsen, O., Alexander, C.M., and Werb, Z. (1992). Metallopro-
Bone Marrow Transplantation teinases mediate extracellular matrix degradation by cells from
Newborn pups were sublethally X-irradiated with 300 cGy. Wild- mouse blastocyst outgrowths. Development 114, 447±456.
type bone marrow cells were obtained by flushing the cavity of
Birkedal-Hansen, H., Moore, W.G., Bodden, M.K., Windsor, L.J.,freshly dissected syngeneic adult femurs and tibias with PBS.
Birkedal-Hansen, B., DeCarlo, A., and Engler, J.A. (1993). MatrixFlushed cells were dispersed by pipetting, washed, and resus-
metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197±250.pended in PBS. Nucleated cells (5 3 107) in 50 ml were injected
Brown, R.A., Taylor, C., McLaughlin, B., McFarland, C.D., Weiss,intraperitoneally into irradiated mice. Neomycin at 2 mg/ml was
J.B., and Ali, S.Y. (1987). Epiphyseal growth plate cartilage andadded to the water of the nursing mother. Pups were killed at 3 and
chondrocytes in mineralising cultures produce a low molecular mass4 weeks after transplantation. To verify engraftment, the spleens
angiogenic procollagenase activator. Bone Miner. 3, 143±58.were used to test for gelatinase B expression by gelatin zymography.
Brown, C.C., Hembry, R.M., and Reynolds, J.J. (1989). Immunolocal-
ization of metalloproteinases and their inhibitor in the rabbit growth
Collagen Gel Angiogenesis Assays plate. J. Bone Joint Surg. Am. 71, 580±593.
Bovine capillary endothelial cells (BCE) were trypsinized and resus- Caplan, A.I. (1988). Bone development. Ciba Found. Symp. 136,
pended in DMEM with 10% calf serum. Cells (4 3 105/ml) were mixed 3±21.
1:1 with a chilled collagen solution (Vitrogen 100, Collagen Corp., Carlevaro, M.F., Albini, A., Ribatti, D., Gentili, C., Benelli,R., Cermelli,
Palo Alto, CA) in MEM medium containing 0.1% NaHCO3, 2 mM S., Cancedda, R., and Cancedda, F.D. (1997). Transferrin promotes
glutamine, and 10 mM HEPES. Aliquots (250 ml) of the collagen- endothelial cell migration and invasion: implication in cartilage neo-
cell mixture were pipetted into 48-well tissue culture plates, and vascularization. J. Cell Biol. 136, 1375±1384.
cartilage pieces were added to each well before the solution was
Chen, Z.L., and Strickland, S. (1997). Neuronal death in the hippo-allowed to gel at 378C. Culture plates were incubated in a 10% CO2,
campus is promoted by plasmin-catalyzed degradation of laminin.balance air atmosphere and observed for endothelial cell growth,
Cell 91, 917±925.migration, and tube formation.
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. (1996).
Fibroblast growth factor receptor 3 is a negative regulator of bone
growth. Cell 84, 911±921.Acknowledgments
Descalzi Cancedda, F., Melchiori, A., Benelli, R., Gentili, C., Masiello,
We thank Adrian Erlebacher for helpful discussions, Juanito Men- L., Campanile, G., Cancedda, R., and Albini, A. (1995). Production
eses and Roger Pedersen for assistance with embryonic stem cells of angiogenesis inhibitors and stimulators is modulated by cultured
and blastocyst injection, Anh Le for assistance with in situ hybridiza- growth plate chondrocytes during in vitro differentiation: depen-
tions, Qin Han for assistance with immunohistochemistry, Ole Beh- dence on extracellular matrix assembly. Eur. J. Cell Biol. 66, 60±68.
rendtsen for assistance with enzymology and graphics, and Cather- Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., andKarsenty, G. (1997).
ine Butterfield for the gift of bovine capillary endothelial cells. This Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.
study was supported by grants from the National Institutes of Health Cell 89, 747±754.
(DE10306 and HD26732 to Z. W. and HL47328 to R. M. S), by a
Elima, K., Eerola, I., Rosati, R., Metsaranta, M., Garofalo, S., Perala,
grant from the National Cancer Institute (CA37395) to D. H., by a
M., De Crombrugghe, B., and Vuorio, E. (1993). The mouse collagen
National Research Service Award (HL07185) and a fellowship from
X gene: complete nucleotide sequence, exon structure and expres-
the American Lung AssociationCalifornia Affliate to T. H. V., a Parker
sion pattern. Biochem. J. 289, 247±253.
B. Francis Fellowship to J. M. S., a Deutsche Forschungsge-
Farnum, C.E., and Wilsman, N.J. (1989). Cellular turnover at themeinschaft fellowship to G. B., and by the Alan A. and Edith L.
chondro-osseous junction of growth plate cartilage: analysis by se-Wolff Charitable Trust and the Marc and Marjorie Seldin Pulmonary
rial sections at the light microscopical level. J. Orthop. Res. 7,Research Fund to R. M. S.
654±666.
Fisher, S.J., and Werb, Z. (1995). The catabolism of extracellular
matrix components. In Extracellular Matrix Molecules: A PracticalReceived February 2, 1998; revised March 18, 1998.
Cell
422
Approach, M.A. Haralson and J.R. Hassell, eds. (Oxford, UK: IRL the gene in osteoclasts, and in some hypertrophying chondrocytes
during mouse development. FEBS Lett. 393, 307±313.Press at Oxford University Press), pp. 261±287.
Fisher, C., Gilbertson-Beadling, S., Powers, E.A., Petzold, G., Poor- Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I., and Tryggvason,
K. (1994). High expression of 92-kD type IV collagenase (gelatinaseman, R., and Mitchell, M.A. (1994). Interstitial collagenase is required
for angiogenesis in vitro. Dev. Biol. 162, 499±510. B) in the osteoclast lineage during mouse development. J. Cell Biol.
124, 1091±1102.Grigoriadis, A.E., Wang, Z.Q., Cecchini, M.G., Hofstetter, W., Felix,
R., Fleisch, H.A., and Wagner, E.F. (1994). c-Fos: a key regulator of Schenk, R.K., Wiener, J., andSpiro, D. (1968). Fine structural aspects
of vascular invasion of the tibial epiphyseal growth plate of growingosteoclast-macrophage lineage determination and bone remodel-
ing. Science 266, 443±448. rats. Acta Anat. 69, 1±17.
Schnaper, H.W., Grant, D.S., Stetler-Stevenson, W.G., Fridman, R.,Hatori, M., Klatte, K.J., Teixeira, C.C., and Shapiro, I.M. (1995). End
labeling studies of fragmented DNA in the avian growth plate: evi- D'Orazi, G., Murphy, A.N., Bird, R.E., Hoythya, M., Fuerst, T.R.,
French, D.L., et al. (1993). Type IV collagenase(s) and TIMPs modu-dence of apoptosis in terminally differentiated chondrocytes. J.
Bone Miner. Res. 10, 1960±1968. late endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156,
235±246.Ingber, D.E., and Folkman, J. (1989). How does extracellular matrix
control capillary morphogenesis? Cell 58, 803±805. Sires, U.I., Schmid, T.M., Fliszar, C.J., Wang, Z.Q., Gluck, S.L., and
Welgus, H.G. (1995). Complete degradation of type X collagen re-Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T., and Itohara, S.
quires the combined action of interstitial collagenase and osteo-(1997). Unaltered secretion of beta-amyloid precursor protein in
clast-derived cathepsin-B. J. Clin. Invest. 95, 2089±2095.gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol.
Chem. 272, 22389±22392. Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991).
Targeted disruption of the c-src proto-oncogene leads to os-Iwasaki, M., Le, A.X., and Helms, J.A. (1997). Expression of indian
teopetrosis in mice. Cell 64, 693±702.hedgehog, bone morphogenetic protein 6 and gli during skeletal
morphogenesis. Mech. Dev. 69, 197±202. Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H.M.,
and Tabin, C.J. (1996). Regulation of rate of cartilage differentiationJingushi, S., Scully, S.P., Joyce, M.E., Sugioka, Y., and Bolander,
by Indian hedgehog and PTH-related protein. Science 273, 613±622.M.E. (1995). Transforming growth factor-beta 1 and fibroblast
growth factors in rat growth plate. J. Orthop. Res. 13, 761±768. Vu, T.H., and Werb, Z. (1998). Gelatinase B: structure, regulation,
and function. In Matrix Metalloproteinases, W.C. Parks and R.P.Karelina, T.V., Goldberg, G.I., and Eisen, A.Z. (1995). Matrix metallo-
Mecham, eds. (San Diego: Academic Press), pp. 115±148.proteinases in blood vessel development in human fetal skin and
in cutaneous tumors. J. Invest. Dermatol. 105, 411±417. Werb, Z. (1997). ECM and cell surface proteolysis: regulating cellular
ecology. Cell 91, 439±442.Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi,
K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., et al. (1997). Whitelock, J.M., Murdoch, A.D., Iozzo, R.V., and Underwood, P.A.
(1996). The degradation of human endothelial cell-derived perlecanTargeted disruption of Cbfa1 results in a complete lack of bone
formation owing to maturational arrest of osteoblasts. Cell 89, and release of bound basic fibroblast growth factor by stromelysin,
collagenase, plasmin, and heparanases. J. Biol. Chem. 271, 10079±755±764.
10086.Kuettner, K.E., and Pauli, B.U. (1983). Vascularity of cartilage. In
Cartilage, B.K. Hall, ed. (New York: Academic Press), pp. 281±312. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S.,
Okamura, H., Sudo, T., Shultz, L.D., and Nishikawa, S. (1990). TheLanske, B., Karaplis, A.C., Lee, K., Luz, A., Vortkamp, A., Pirro, A.,
murine mutation osteopetrosis is in the coding region of the macro-Karperien, M., Defize, L.H.K., Ho, C., Mulligan, R.C., et al. (1996).
phage colony stimulating factor gene. Nature 345, 442±444.PTH/PTHrP receptor in early development and Indian hedgehog-
regulated bone growth. Science 273, 663±666.
Lewinson, D., and Silbermann, M. (1992). Chondroclasts and endo-
thelial cells collaborate in the process of cartilage resorption. Anat.
Rec. 233, 504±514.
Moses, M.A., and Langer, R. (1991). A metalloproteinase inhibitor
as an inhibitor of neovascularization. J. Cell. Biochem. 47, 230±235.
Murphy, A.N., Unsworth, E.J., and Stetler-Stevenson, W.G. (1993).
Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced hu-
man microvascular endothelial cell proliferation. J. Cell. Physiol.
157, 351±358.
Naldini, L., Vigna, E., Bardelli, A., Follenzi, A., Galimi, F., and Comog-
lio, P.M. (1995). Biological activation of pro-HGF (hepatocyte growth
factor) by urokinase is controlled by a stoichiometric reaction. J.
Biol. Chem. 270, 603±611.
Ohsawa, Y., Nitatori, T., Higuchi, S., Kominami, E., and Uchiyama,
Y. (1993). Lysosomal cysteine and aspartic proteinases, acid phos-
phatase, and an endogenous cysteine proteinase inhibitor, cystatin-
beta, in rat osteoclasts. J. Histochem. Cytochem. 41, 1075±1083.
Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C.,
Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen,
B.R., et al. (1997). Cbfa1, a candidate gene for cleidocranial dyspla-
sia syndrome, is essential for osteoblast differentiation and bone
development. Cell 89, 765±771.
Pfeifer, A., Aszodi, A., Seidler, U., Ruth, P., Hofmann, F., and Fassler,
R. (1996). Intestinal secretory defects and dwarfism in mice lacking
cGMP-dependent protein kinase II. Science 274, 2082±2086.
Poole, A.R. (1991). The growth plate: cellular physiology, cartilage
assembly and mineralization. In Cartilage: Molecular Aspects, B.K.
Hall and S.A. Newman, eds. (Boca Raton: CRC Press), pp 179±211.
Rantakokko, J., Aro, H.T., Savontaus, M., and Vuorio, E. (1996).
Mouse cathepsin K: cDNA cloning and predominant expression of
